Pear Therapeutics- Warrants (01/12/2026) Accounts Payable

As of the most recent data (December 2022), PEARW shows a accounts payable of $3.3M. That compares with $1.8M in the prior-year period — up 80.7% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, PEARW's accounts payable is now $3.3M (was $1.8M) — a 80.7% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Pear Therapeutics- Warrants (01/12/2026) is outperforming or lagging.

Tracking PEARW's accounts payable over time shows whether Pear Therapeutics- Warrants (01/12/2026) is scaling, shrinking, or reshaping that part of the business. The current reading is $3.3M That compares with $1.8M in the prior-year period — up 80.7% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has Pear Therapeutics- Warrants (01/12/2026)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $3.3M) with ownership activity and broader fundamentals.